Characterization of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases
Abstract
There is now considerable experimental evidence that aberrant activation of Rho family small GTPases promotes uncontrolled proliferation, invasion, and metastatic properties of human cancer cells. Therefore, there is considerable interest in the development of small molecule inhibitors of Rho GTPase function. However, to date, most efforts have focused on inhibitors that block Rho GTPase function indirectly, either by targeting enzymes involved in post-translational processing or downstream protein kinase effectors. We have reported the identification and characterization of the EHT 1864 small molecule as an inhibitor of Rac family small GTPases, placing Rac1 in an inert and inactive state and then impairing Rac1-mediated functions in vivo. Our work suggests that EHT 1864 selectively inhibits Rac1 downstream signaling and cellular transformation by a novel mechanism involving guanine nucleotide displacement. This chapter provides the details for some of the biochemical and biological methods used to characterize the mode of action of EHT 1864 on Rac1 and its impact on Rac1-dependent cellular functions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
EHT 1864 is a Rac inhibitor.
“Rac inhibitor EHT 1864”
The citation lists haven’t been fetched yet
References 33 · Cited by 126
- Authors
- Onesto, C., Shutes, A., Picard, V., Schweighoffer, F., & Der, C. J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- ORCID
- Channing J. Der
- Venue
- Methods in Enzymology
- Publisher
- Elsevier
- Published
- 2008
- Volume
- 439
- Pages
- 111-129
- ISSN
- 0076-6879 (ISSN-L)
- OpenAlex
- W1574913479
- Cited by
- 126
- References
- 33
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 9 · 2020: 7 · 2019: 8 · 2018: 2 · 2017: 6 · 2016: 8 · 2015: 11 · 2014: 5 · 2013: 10 · 2012: 8
- FWCI
- 3.02
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- Locations
- Methods in enzymology on CD-ROM/Methods in enzymology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA063071, CA67771, CA92240)
- Susan G. Komen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- Rac1, small molecule inhibitors, Rac1 activation, cell transformation, metastasis
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Fluorescent Antibody Technique, Humans, Pyrones, Quinolines, Microscopy, Confocal, rac1 GTP-Binding Protein, Fluorescence Resonance Energy Transfer, NIH 3T3 Cells, Mice, p21-Activated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review